Daiwa Securities Group Inc. Homology Medicines, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$8.92 - $13.29 $1,329 - $1,980	-149 Reduced 59.84%	100 $1,000
Q4 2019 Jan 31, 2020	SELL	$11.42 - $22.19 $354 - $687	-31 Reduced 11.07%	249 $5,000
Q3 2019 Nov 04, 2019	BUY	$14.74 - $22.28 $619 - $935	42 Added 17.65%	280 $5,000
Q1 2019 Apr 26, 2019	SELL	$19.76 - $29.57 $2,213 - $3,311	-112 Reduced 32.0%	238 $7,000
Q4 2018 Feb 05, 2019	BUY	$18.39 - $26.3 $6,436 - $9,205	350 New	350 $8,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.